Blog From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.By James Lu, MD, PhD, CEO and Co-Founder of Helix
Press ReleasesHelix GenoSphere™ Launches MASH-Enriched Cohort of Over 17,000 Linked Clinico-Genomic Records to Accelerate Drug Discovery and DevelopmentOctober 15, 2025
Press ReleasesHelix to Present New Population-Scale Genomic Research at ASHG 2025 Annual MeetingOctober 7, 2025
VideosPartner Perspectives with Nebraska MedicineGenetic Insights Project helps Nebraskans take charge of their health
1Published ResearchPopulation Genomic Screening and Improved Lipid Management in Patients With Familial HypercholesterolemiaNovember 5, 2025
2Published ResearchFrom Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World EvidenceAugust 15, 2025
3Published ResearchNovel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse CohortJuly 30, 2025
4Published ResearchChatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering ProjectJune 10, 2025
5Published ResearchIndividuals with PMS2 pathogenic variants are at average risk of cancer before age 60March 19, 2025
Blog From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.By James Lu, MD, PhD, CEO and Co-Founder of Helix
Press ReleasesHelix GenoSphere™ Launches MASH-Enriched Cohort of Over 17,000 Linked Clinico-Genomic Records to Accelerate Drug Discovery and DevelopmentOctober 15, 2025
Press ReleasesHelix to Present New Population-Scale Genomic Research at ASHG 2025 Annual MeetingOctober 7, 2025
VideosPartner Perspectives with Nebraska MedicineGenetic Insights Project helps Nebraskans take charge of their health
1Published ResearchPopulation Genomic Screening and Improved Lipid Management in Patients With Familial HypercholesterolemiaNovember 5, 2025
2Published ResearchFrom Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World EvidenceAugust 15, 2025
3Published ResearchNovel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse CohortJuly 30, 2025
4Published ResearchChatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering ProjectJune 10, 2025
5Published ResearchIndividuals with PMS2 pathogenic variants are at average risk of cancer before age 60March 19, 2025
ResearchJan 28, 2020Genome-wide rare variant analysis for thousands of phenotypes in over 70,000 exomes from two cohortsNATURE COMMUNICATIONS
Press ReleasesJan 9, 2020Mayo Clinic to sequence 100K participants to build genomic database for improved care and research in collaboration with Helix
Press ReleasesJan 9, 2020Mayo Clinic to Sequence 100,000 Participants to Build Genomic Database for Improved Care and Research in Collaboration with Helix
ResearchOct 17, 2019Are we ready to implement polygenic risk score tests in the clinic? Expanding the utility of prostate cancer polygenic risk score in multiple ethnicities and clinical best practicesASHG 2019
ResearchOct 17, 2019Applying Confidence Intervals to Clinical Polygenic Risk Scores in 60,000 Exome+ Sequenced IndividualsASHG 2019
ResearchOct 17, 2019Genome-wide rare variant analysis for thousands of phenotypes in >70,000 exomesASHG 2019